Last reviewed · How we verify

NCT06281262: PRIME

Selected Immunological Indicators and Microbiota in Patients With Premature Birth and Preeclampsia

Status unknown Last updated 1 March 2024
What this trial tests

trial testing Peripheral blood collection in Preterm Birth in 100 participants. Status unknown.

Timeline
30 June 2023
Primary endpoint
30 March 2025
30 March 2025

Quick facts

Lead sponsorGeneral University Hospital, Prague
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date30 June 2023
Primary completion30 March 2025
Estimated completion30 March 2025
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

General University Hospital, Prague

Who can join

Adults 19 to 40, female only, with Preterm Birth or Preeclampsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal is to demonstrate the relationship of the circulating pool of T-regulatory lymphocytes in the mother's peripheral blood with populations in the placentas and to compare with controls, what is the difference in the expression of individual regulatory molecules of T-regulatory lymphocytes according to new paradigms. The proportional and functional characteristics of T-regulatory lymphocytes will be correlated with the composition of the intestinal and vaginal microbiota.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Peripheral blood collection

Trials testing the same drug.

Other recruiting trials for Preterm Birth

Currently open trials in the same condition.

Other General University Hospital, Prague trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06281262.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing